Companies / Volitionrx Ltd

Volitionrx Ltd

NYSE: VNRXCIK 93314HENDERSON, NV

Financials · FY2025

Revenue$1.73M
Net income$-23.50M
Total debt$7.62M
Cash$2.80M
Diluted EPS$-0.31
Shares outstanding8.3M

Ownership

8.3M shares outstanding · as of May 7, 2026
123.8%Insiders
Ownership
Insiders123.76%10,309,310
10%+ / strategic227.91%18,985,341
Institutions0.68%56,303
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 16

View all →
Insider% of sharesShares
Reynolds Cameron JohnCEOPresident and CEO · Director
37.40%3,115,547
Still Timothy IDirector
19.51%1,625,458
Innes Guy ArchibaldDirector
15.04%1,252,967
Hughes TerigChief Financial Officer
8.22%684,970
Micallef Jacob VincentChief Scientific Officer
6.87%572,179
Kway JasmineCEOCEO - Singapore Volition
5.03%418,614
Plummer NicholasGC - Volition Diagnostics
4.89%407,267
Butera Salvatore ThomasCEOCEO - Volition Veterinary
4.50%375,203
Forterre GaelChief Commercial Officer
3.98%331,338
Batchelor Ann-LouiseGroup Chief Marketing Officer
3.89%324,072

Institutional holders 2

View all →
HolderValue% of shares
State Street Corporation$45.9K0.41%
BlackRock, Inc.$30.1K0.27%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
State Street Corporation
13F manager
NewCommon Stock$45.9K+34K
33,995
0.41% of shares
low
Q2 2026
as of
BlackRock, Inc.
13F manager
NewCommon Stock$30.1K+22K
22,308
0.27% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Armistice Capital, LLCPassive13G/A—6,449,635—
Lagoda Investment Management, L.P.Passive13G/A—12,535,706—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
VNRXCommon StockEquity928661206BBG000BQWFH2